5 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 61
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Budenofalk 4 mg zetpillenZetpil | Budesonide | Netherlands | Authorised | 2022 |
| Budenofalk 9 mg maagsapresistent granulaatMaagsapresistent granulaat | Budesonide | Netherlands | Authorised | 2011 |
| Budenofalk, maagsapresistente capsules 3 mgMaagsapresistente capsule, hard | Budesonide | Netherlands | Authorised | 2000 |
| Budenofalk Schuim 2 mg, schuim voor rectaal gebruikSchuim voor rectaal gebruik | Budesonide | Netherlands | Authorised | 2011 |
| Budosan 2 mg rektalna pjenaRektalna pjena | Budesonide | Croatia | Marketed | 2021 |
| Budosan 3 mg želučanootporne kapsuleželučanootporna kapsula, tvrda | Budesonide | Croatia | Marketed | 2021 |
| Budosan 4 mg čepićičepić | Budesonide | Croatia | Authorised | 2023 |
| IMMUFALK 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg · Comprimido recubierto con película | Azathioprine | Spain | Marketed | 2017 |
| IMMUFALK 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA75 mg · Comprimido recubierto con película | Azathioprine | Spain | Marketed | 2017 |
| INTESTIFALK 2 mg/DOSIS ESPUMA RECTAL2 mg · Espuma rectal | Budesonide | Spain | Marketed | 2009 |
| INTESTIFALK 3 mg CAPSULAS GASTRORRESISTENTES3,00 mg · Cápsula dura gastrorresistente | Budesonide | Spain | Marketed | 2004 |
| INTESTIFALK 4 MG SUPOSITORIOS4 mg · Supositorio | Budesonide | Spain | Marketed | 2023 |
| INTESTIFALK UNO 9 mg GRANULADO GASTRORRESISTENTE9,0 mg · Granulado gastrorresistente | Budesonide | Spain | Marketed | 2012 |
| Jorveza | Budesonide | EU (EMA) | Authorised | 2018 |
| Jorveza 0,2 mg/ml suspensie voor oraal gebruikSuspensie voor oraal gebruik | Budesonide | Netherlands | Authorised | 2026 |
| JORVEZA 0,2 MG/ML SUSPENSION ORAL0,20 mg/ml · Suspensión oral | Budesonide | Spain | Authorised | 2026 |
| JORVEZA 0,5 MG COMPRIMIDOS BUCODISPERSABLES0,5 mg · Comprimido bucodispersable | Budesonide | Spain | Marketed | 2020 |
| Jorveza 0,5 mg, orodispergeerbare tabletOrodispergeerbare tablet | Budesonide | Netherlands | Authorised | 2018 |
| JORVEZA 1 MG COMPRIMIDO BUCODISPERSABLE1 mg · Comprimido bucodispersable | Budesonide | Spain | Marketed | 2018 |
| Jorveza 1mg orodispergeerbare tablettenOrodispergeerbare tablet | Budesonide | Netherlands | Authorised | 2018 |
| SALOFALK 1,5 g GRANULADO DE LIBERACION PROLONGADA1500,00 mg · Granulado de liberación modificada | Mesalazine | Spain | Marketed | 2008 |
| Salofalk 1,5g Granu-Stix, granulaat met verlengde afgifteGranulaat met verlengde afgifte | Mesalazine | Netherlands | Authorised | 2008 |
| Salofalk 1 g čepićičepić | Mesalazine | Croatia | Marketed | 2021 |
| SALOFALK 1 g SUPOSITORIOS1000 mg · Supositorio | Mesalazine | Spain | Marketed | 2011 |
| Salofalk 1000 mg Granu-Stix, granulaat met verlengde afgifteGranulaat met verlengde afgifte | Mesalazine | Netherlands | Authorised | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 22 | 22 | 0 | CompaniesAll medicines |
| Spain | 17 | 15 | 2 | CompaniesAll medicines |
| Croatia | 11 | 11 | 0 | CompaniesAll medicines |
| Romania | 10 | 0 | 10 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, France, Italy, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Report an error or request removalCorrections from the company itself are welcome.
Keep FALK’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Well-known pharmaceutical groups, each with all its companies.
